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The frequency of the most common sporadic Apert syndrome mutation (C755G) in the human fibroblast growth factor
receptor 2 gene (FGFR2) is 100–1,000 times higher than expected from average nucleotide substitution rates based on
evolutionary studies and the incidence of human genetic diseases. To determine if this increased frequency was due to
the nucleotide site having the properties of a mutation hot spot, or some other explanation, we developed a new
experimental approach. We examined the spatial distribution of the frequency of the C755G mutation in the germline
by dividing four testes from two normal individuals each into several hundred pieces, and, using a highly sensitive PCR
assay, we measured the mutation frequency of each piece. We discovered that each testis was characterized by rare
foci with mutation frequencies 10
3 to .10
4 times higher than the rest of the testis regions. Using a model based on
what is known about human germline development forced us to reject (p , 10
 6) the idea that the C755G mutation
arises more frequently because this nucleotide simply has a higher than average mutation rate (hot spot model). This is
true regardless of whether mutation is dependent or independent of cell division. An alternate model was examined
where positive selection acts on adult self-renewing Ap spermatogonial cells (SrAp) carrying this mutation such that,
instead of only replacing themselves, they occasionally produce two SrAp cells. This model could not be rejected given
our observed data. Unlike the disease site, similar analysis of C-to-G mutations at a control nucleotide site in one testis
pair failed to find any foci with high mutation frequencies. The rejection of the hot spot model and lack of rejection of a
selection model for the C755G mutation, along with other data, provides strong support for the proposal that positive
selection in the testis can act to increase the frequency of premeiotic germ cells carrying a mutation deleterious to an
offspring, thereby unfavorably altering the mutational load in humans. Studying the anatomical distribution of
germline mutations can provide new insights into genetic disease and evolutionary change.
Citation: Qin J, Calabrese P, Tiemann-Boege I, Shinde DN, Yoon SR, et al. (2007) The molecular anatomy of spontaneous germline mutations in human testes. PLoS Biol 5(9):
e224. doi:10.1371/journal.pbio.0050224
Introduction
Current methods to measure directly the frequency at
which human germline nucleotide substitutions arise each
generation include the analysis of sporadic cases of human
autosomal dominant or sex-linked diseases [1,2] and DNA
analysis of sperm [3–5]. Studies of the ﬁbroblast growth factor
receptor 2 gene (FGFR2) using both approaches [3,4,6,7] have
been useful in understanding the origins of Apert syndrome.
Individuals born with this condition are characterized by a
number of features, including prematurely fused cranial
sutures and fused ﬁngers and toes (see accession numbers).
This dominantly inherited disease arises with a frequency
between 10
 5 and 10
 6 [6,7] virtually always due to a
spontaneous germline mutation,. Surprisingly, the high
incidence of Apert syndrome cannot be explained by
mutations at numerous nucleotide sites in the FGFR2 gene
leading to the disease phenotype. In fact, greater than 98% of
Apert syndrome cases arise by transversion mutations at only
two sites (C755G and C758G). The C755G mutation is located
at a CpG [dinucleotide containing a C followed by a G (59 to
39)] site (leading to a serine-to-tryptophan substitution at
amino acid 252) and accounts for two-thirds of the cases [8,9].
Based on what is known about the frequency of transversion
mutations at neutral CpG sites since humans and chimpan-
zees last had a common ancestor [10] and mutations at many
human disease loci [11], the C755G mutation frequency is
100–1,000-fold greater than expected. One intuitive explan-
ation is that this nucleotide simply has a higher than average
chance of undergoing a base substitution (mutation hot spot
model). Alternatively, positive selection for diploid germline
cells carrying the mutation has also been proposed [4,5,12,13].
In fact, the authors of one study [4] argued that positive
selection on mutant spermatogonia was required to explain
their results on sperm mutation frequencies. We show,
however, that this same data is also compatible with the
mutation hot spot model (Text S1 and Figure S1). With
speciﬁc regard to human germline selection being respon-
sible for the high C755G mutation frequency, it has been said
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PLoS BIOLOGYthat ‘‘Surprising hypotheses call for unusually strong evi-
dence’’ [14]. We have therefore developed a new approach to
distinguish between the selection and hot spot models that
goes beyond sperm analysis.
Results
Analysis of Individual Testes and Their Associated
Epididymides
We studied the spatial distribution of C755G mutations
within both testes from each of two normal individuals. The
source of the testes, their dissection into small pieces, the
puriﬁcation and quantitation of DNA, and the quantitative
mutation detection assay are described in Materials and
Methods, Figure 1, Text S1, and Figures S2–S4. For testis 374–
1, the mutation frequencies of 192 individual pieces ranged
from ,10
 6 (no mutants found among one million genomes)
to as high as 0.027 with an average frequency of 3.8 3 10
 4
(Table 1). This latter value was close to that observed for an
epididymal sperm sample taken from the proximal vas
deferens and distal epididymis of the same testis (4.5 3
10
 4). The background mutation frequency of this assay was
between 2.4 3 10
 7 and 6.6 3 10
 8 (see Materials and
Methods).
For testis 374–2, the mutation frequency for the individual
pieces varied from ,10
 6 to 0.007. The average frequency (6.7
310
 5) was lower than that of testis 374–1 but was consistent
with the epididymal sperm sample (3.9 3 10
 5) for this testis.
The detailed data on the total DNA content and mutation
frequency of each piece for these two testes (and the two
additional testes examined below) are presented in Table S1.
When the data from testes 374–1 and 374–2 are combined,
the estimated sperm mutation frequency for this donor is
similar to the highest sperm mutation frequencies of normal
men of similar age using sperm as a DNA source [3,4]
(unpublished data).
Figure 2A and 2B shows the distribution of the mutation
frequencies throughout both testes. Each one is characterized
by a very small number of ‘‘hot’’ pieces with very high
mutation frequencies compared with the mutation frequen-
cies of the remaining pieces. We also calculated the minimum
number of pieces which together contained 95% of the
mutant genomes. In testis 374–1, 12 of the 192 pieces satisﬁed
this criterion. These 12 pieces contain only 5.7% of the DNA
in this testis, whereas we might have expected that according
to a random spatial distribution, many more pieces which
together contain 95% of the genomes would have been
required. The results for testis 374–2 were quite similar: of
the 192 pieces, 95% of the mutant molecules came from ﬁve
pieces whose total DNA content was only 2.6% of the total
testis. In many cases, several pieces with high mutation
frequencies appear to form foci adjacent to one another in
one slice or even between slices (Figure 2A and 2B).
Analysis of a Second Pair of Testes Partially at Higher
Resolution
We ﬁrst analyzed the mutation frequency distribution in a
portion (approximately one-quarter) of testis 854–1. By
dissecting this portion into 192 pieces (UL in Figure S2), we
achieved a resolution four times higher than used for testes
374–1 and  2. The mutation frequencies of the pieces varied
from ,2 3 10
 6 to 0.06. We found that 98% of the mutants
were derived from only three of the 192 pieces (Figure 2C).
Figure 1. Testes Dissection Strategy
Testes 374–1, 374–2, and 854–2. After slicing each testis in half,
perpendicular to the epididymal axis, the two halves were each divided
into three slices along the same axis for a total six slices. Each slice is then
cut into 32 pieces and each piece is numbered (see inset for slice 3) to
provide a binomial classification system (e.g., slice 3 piece 17). Note that
there is some variation in slice and piece size because of the shape of the
testis. This is reflected in the number of genomes per piece (see Table S1).
doi:10.1371/journal.pbio.0050224.g001
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Author Summary
Some human disease mutations occur 100–1,000 times more
frequently than would be predicted from genome wide studies of
mutation in different species. In Apert syndrome, for example, two-
thirds of all new causal mutations occur at only one base in the
affected gene. This unusually high frequency suggests that some-
thing about that DNA base or its local surroundings makes it highly
susceptible to mutation. We studied this hypothesis by examining
the location of cells containing this mutation in the testes of normal
men. We found that mutant cells were not uniformly distributed
throughout the testes, as would be expected for random mutations.
Instead, we found 95% of the mutants in small clusters containing
only a few percent of the total testes cells. A higher-than-average
mutation rate could not explain the data. We propose that these
mutations arise at the expected rate, but that mutated cells gain a
selective advantage that allows them to increase their frequency
compared to nonmutant cells. Our results—which argue against the
mutational hot spot model in favor of a selection model—suggest
how germline selection in animals can alter the mutational load of a
species.These pieces contained 1.6 % of the genomes in this portion
of the testis. The fact that the pieces with the highest
mutation frequencies were approximately one-quarter the
size of pieces analyzed before suggests that the ‘‘hot’’ pieces
from testes 374–1 and  2 studied at the lower resolution
might have contained sub-regions with even higher mutation
frequencies.
The remaining three-quarters of testis 854–1 was analyzed
with the same dissection resolution (Figures 1 and S2) used for
donor 374 and therefore was cut into 144 pieces (¼0.753192).
The mutation frequencies for individual pieces ranged from
,2 3 10
 6 to 0.032. Again, the vast majority of the mutations
(95%) came from a few (six) pieces that contained only a small
fraction of the genomes in this portion (5%). The mutation
distribution is shown in Figure 2D. The total mutation
frequency of testis 854–1 calculated using all the data (4.8 3
10
 4) was quite similar to the epididymal estimate (2.6310
 4).
Finally, we examined testis 854–2 in the same way as 374–1
and 374–2. This testis had the same features found in the
other three: a similar distribution (Figure 2E) and range
(Table 1) of mutation frequencies and an enrichment of
mutant genomes in the hottest pieces (95% of the mutants
come from 2.6% of the testis genomes). Surprisingly, the total
mutation frequency of this testis was quite different from the
epididymal estimate (Table 1). This epididymal sperm DNA
preparation was unique in containing a highly viscous
material, suggesting that the epididymis might have been
subject to some local pathological process that contaminated
the sperm sample with nongermline DNA, thereby explaining
the lower mutation frequency estimate.
In summary, analysis of the distribution of C755G Apert
syndrome mutations in four testes showed a small number of
pieces with very high mutation frequencies among a general
background of lower mutation frequencies. Some of the
pieces had 10
3-t o.10
4-fold higher mutation frequencies
than pieces with the lowest frequencies. In many cases, several
pieces surrounding ‘‘hot’’ regions also had relatively high
mutation frequencies.
Testing the Mutation Hot Spot Model
To understand whether the unexpectedly high C755G
transversion mutation frequency can be explained simply by
an inherently higher probability of mutation at this site, we
asked whether the frequencies and distribution of the C755G
mutations we observed in the testes can be explained by a
plausible model of germline mutation (described in the
Materials and Methods section). In this model, we make use of
data on human germline development and maturation[1,15–
28]. Our model has two phases (Figure 3). In the ﬁrst phase
between zygote formation and puberty, called the growth
phase, the male germline cells divide symmetrically and thus
increase in number exponentially. At each division, there is a
probability of a mutation at the disease site. The exponential
increase in cell number can magnify the inﬂuence of any
single mutation on the mutation frequency if it occurs early
enough in development. This concept, ﬁrst noted by Luria
and Delbruck [29] in bacteria, can lead to a ‘‘mutation
jackpot.’’ Because the germ cells would be expected to stay in
close proximity to their ancestors, any such early mutations
will result in regions of the testis with high mutation
frequencies. The germ cells of the growth phase eventually
form the adult self-renewing Ap spermatogonia (SrAp). In the
second phase, called the adult phase, SrAp divide asymmetri-
cally to produce a daughter SrAp (self-renewal) and another
daughter cell, whose descendants, after only a few additional
divisions, will produce sperm. During the adult phase, the
number of SrAp remains approximately constant, and each
new mutation in this phase produces only one mutated SrAp
cell lineage. There are many more SrAp cell divisions during
the adult phase than there are SrAp precursor cell divisions
during the growth phase; for a 50–60-y-old man, the ratio of
mutations expected to occur in the adult phase, compared to
the growth phase, is approximately 500 to 1 (see Materials and
Methods).
We have written a computer program to simulate the
model (Protocol S1). The code can also be downloaded from
http://rd.plos.org/pbio.0050224. This program allows us to
estimate model parameters and test the hypothesis that the
data are consistent with this model. A key model parameter is
the nucleotide substitution rate per cell division. We infer
this value by ﬁnding that rate that, in simulations, is most
likely to match the overall C755G testis mutation frequency.
Even though this frequency is very high relative to data on
transversion frequencies at other CpG sites [10,11], the
Table 1. Summary Data on Four Testes




Number of Pieces Containing





374–1 62 y 3.8 3 10
 4 (,10
 6–0.027) 4.5 3 10
 4 12
a (1.4 3 10
 3–0.027) 5.7
374–2 62 y 6.7 3 10
 5 (,10




854–2 54 y 6.8 3 10
 4 (,2 3 10
 6–0.047) 1.1 3 10
 4 7
a (3 3 10
 3–0.047) 5.0
854–1 TOTAL 54 y 4.8 3 10




854–1 (UL) 54 y 4.2 3 10
 4 (,2 3 10
 6–0.06) —
c 3
b (1.4 3 10
 2–0.06) 0.5
e
854–1 (URþTH) 54 y 5.9 3 10
 4 (,2 3 10
 6–0.032) —
c 6
a (1.4 3 10
 3–0.032) 3.4
a Based on a resolution of 192 pieces/testis.
bThe resolution was 192/pieces per ;1/4 testis.
c The epididymal sperm mutation frequency only reflects the whole testis.
dDifferent piece sizes prevent a direct calculation for the whole testis.
eThe high resolution dissection for this portion could contribute to the low percent value.
UL, upper left; UR, upper right; TH, tail half.
doi:10.1371/journal.pbio.0050224.t001
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Human Germline Mutationinferred C755G mutation rate per cell division is still low
enough that mutations early in the growth phase with the
potential to produce a jackpot are unlikely. In those
simulations with this inferred rate, almost all of the mutations
occur in the adult phase or late in the growth phase, and
consequently, there is little variation in the mutation
frequency of the testis pieces: 95% of the mutants are found
distributed among 95% of the testis pieces. This contrasts
sharply with the experimental data where the mutation
frequency varies greatly between testis pieces, and 95% of the
mutant genomes are found in only a few testis pieces
containing between 2.6% and 5.7% of the total genomes. In
simulations, when we increase the mutation rate per cell
division so that more mutations occur in the growth phase,
there are so many mutations in the adult phase that the
overall testis mutation frequency is much greater than that
found in the actual data.
To test whether the observed distribution of the mutation
frequencies among the testis pieces is consistent with the
model, we performed both a goodness-of-ﬁt test and a chi-
squared test (see Materials and Methods). The mutation hot
spot model was rejected (p , 10
 6) (Table 2). We reached the
same conclusion when we considered a model with repli-
cation-independent mutations (or a model with both repli-
cation-dependent and replication-independent mutations),
since the adult phase lasts much longer than the growth phase
Figure 2. Distribution of C755G Mutants in Dissected Human Testes
For dissection details, see Figure 1 and Figure S2. In every case, the orientation of the testis is given relative to the head and tail portions of the
epididymis. Each panel consists of six slices, each divided into 32 pieces, with exceptions noted below. The color code shows the number of mutant
molecules per million genomes. (A) Testis 374–1. (B) Testis 374–2. (C) Testis 854–1, Upper left (UL) portion (Figure S2). The sizes of the 192 pieces are
;1/4 the size of the pieces shown in the other panels. (D) Testis 854–1 Upper rightþTail half portions (URþTH). The vertical white rectangles (pieces 1–
16 in the first three slices) indicate the source of the UL portion shown in panel (C). (E) Testis 854–2.
doi:10.1371/journal.pbio.0050224.g002
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Human Germline Mutation(see Materials and Methods). Our data provide strong support
for rejecting the most intuitive explanation for the high
frequency of C755G mutations: that the site has an inherently
higher probability of undergoing transversion mutations
than does an average CpG site in the genome. We conclude
that this site is not a mutation hot spot, regardless of the
exact molecular mechanism responsible for the C755G
mutation event.
Germline Selection
Incorporating selection as a modiﬁcation to our model can
reproduce both the overall testis mutation frequency and the
distribution of mutation frequencies observed in the testis
pieces. One possibility is that the C755G mutation promotes
rare SrAp symmetric divisions in the adult phase (in the
original model, adult phase divisions were always asymmetric
[16–18,21,24]). The occasional symmetric divisions would
allow mutated SrAp to grow locally in number over time,
and thereby increase the overall mutation frequency in the
testis. We add to our ﬁrst model a selection parameter: at
each adult phase generation, with probability p, a mutated
SrAp divides symmetrically and with probability 1  p it
divides asymmetrically (after a symmetric division, each
daughter SrAp reverts to having asymmetric divisions until
the next rare symmetric division occurs; a similar model was
independently proposed in a recent publication [12]).
We infer the probability p and the mutation rate per cell
division by ﬁtting both the overall testis mutation frequency
and the minimum number of pieces, which together contain
95% of the mutant genomes. The inferred probability p of a
symmetric division is approximately 0.01 (on average, one of
every hundred divisions is symmetric). With this modiﬁcation,
we can no longer reject the model using the chi-squared test
(Table 2): the distribution of frequencies in the testis pieces
now matches the data. In the simulations, foci of high
mutation frequency emerge and, as in the data, these foci
often intersect several adjacent testis pieces. With p near 0.01,
simulations with the inferred mutation rate match the
observed mutation frequencies of the testes (10
 4–10
 5);
however, simulations with this rate, but with p ¼ 0 (the no-
selection case), predict a testis mutation frequency in the
10
 8–10
 10 range for a 20-y-old male. This lower range is
similar to C-to-G mutation frequencies estimated for CpG
sites in the studies on neutral and disease mutations [10,11].
Another difference between the p¼0 (no-selection) and the
p . 0 cases is that for the p ¼ 0 case, the model predicts that
the mutation frequency increases linearly with the man’s age,
whereas for the p . 0 case, this increase is exponential.
Previously, it was suggested [4] that selection could cause the
observed exponential increase in the birth incidence of Apert
syndrome with the father’s age (paternal age effect
[1,12,15,30,31]). To match the observed 20-fold increase
between fathers who are younger than 24 and fathers who
are older than 50 [30], the inferred p value would have to be
approximately 0.004.
There are undoubtedly other models with different forms
of selection on the mutant cells that are also consistent with
the data. A modiﬁcation to the model that does not include
selection, but could reproduce the testis data, is if there was a
higher nucleotide substitution rate per cell division in the
growth phase than in the adult phase. However, this could not
Table 2. Model Parameters and Goodness-of-Fit p-Values
Specimen Hot Spot Model (p ¼ 0) Selection Model (p . 0)
Optimal k, 95% c.i. GOF p-value Optimal k, 95% c.i. Optimal p, 95% c.i. v
2 p-value
Testis 374–1, g ¼ 27 3.3 3 10
 7 (3.2–3.5) 310
 7 ,10
 6 2.2 3 10
 10 (1.0–4.0) 310
 10 0.009 (0.008–0.012) 0.895
Testis 374–1, g ¼ 34 3.3 3 10
 7 (3.0–3.6) 310
 7 ,10
 6 2.6 3 10
 12 (1.0–5.0) 310
 12 0.014 (0.012–0.019) 0.667
Testis 374–2, g ¼ 27 5.7 3 10
 8 (5.4–6.5) 310
 8 ,10
 6 1.0 3 10
 10 (0.1–2.8) 310
 10 0.008 (0.007–0.011) 0.321
Testis 374–2, g ¼ 34 5.6 3 10
 8 (5.3–6.2) 310
 8 ,10
 6 1.1 3 10
 12 (0.3–2.5) 310
 12 0.013 (0.011–0.018) 0.688
Testis 854–2, g ¼ 27 7.0 3 10
 7 (6.6–7.5) 310
 7 ,10
 6 2.2 3 10
 10 (1.0–5.0) 310
 10 0.012 (0.009–0.014) 0.579
Testis 854–2, g ¼ 34 6.8 3 10
 7 (6.6–7.5) 310
 7 ,10
 6 3.0 3 10
 12 (1.0–6.0) 310
 12 0.017 (0.015–0.019) 0.355
The hypothesis test rejects the hot spot model (p¼0) for all testes; it cannot reject the selection model (p . 0). The selection parameter is p; k is the mutation rate per cell division. We
computed everything for the number of growth phase generations g equal to 27, and then repeat these computations for g¼ 34; the true value is presumably between these bounds.
GOF, goodness of fit test (see Methods).
c.i., confidence interval.
doi:10.1371/journal.pbio.0050224.t002
Figure 3. Model Schemes
The models are depicted with only three growth phase generations
leading to eight adult SrAp cells; in actuality there are ;30 growth phase
generations leading to ;10
10 adult SrAp cells. The vertical tick marks
across the top line depict adult phase generations; for the donors in this
paper there are ;1,000 adult phase generations. (A) Mutation hot spot
model (p¼0). There are two mutation events (red crosses): one is in the
adult phase which produces one mutated SrAp cell, while the other one
in the growth phase produces four mutated SrAp cells. (B) Selection
model (p . 0). The one mutation in the adult phase now produces three
mutated SrAp cells.
doi:10.1371/journal.pbio.0050224.g003
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Human Germline Mutationaccount for the paternal age effect, nor do we know of any
evidence to support such a difference.
Testis Distribution of a C-to-G Transversion Mutation at a
Control CpG Site
As a control, we also analyzed the C of a CpG site in an
intron of the CAV1 gene on Chromosome 7, which is
presumably a neutral site. We reanalyzed testis 374–1 and
374–2 using an assay designed for this site (Materials and
Methods). The data are given in Table S2. The total C-to-G
mutation frequency in sperm from epididymis 374–1 was 73
10
 6. The mutation frequency that was estimated by summing
up the individual pieces of the testis was 3.3310
 6. Unlike the
disease site, there was a narrow range of frequencies in these
individual pieces (,4 3 10
 6 to 2 3 10
 5). Ninety-two testis
pieces were required to collect 95% of the mutants; these
pieces contained 50% of the testis’ genomes. Eighty-eight
pieces, containing 46% of the genomes, had mutation
frequencies less than the background of the assay. Therefore
for the testis pieces contributing to the mutation estimate,
88% of the pieces, containing 93% of the genomes, were
required to amass 95% of the total mutations. Moreover,
selection is not required to explain the data, since we could
not reject our model for the neutral mutation case with the
selection parameter p ﬁxed at zero. The data from testis 374–
2 was similar.
The control site mutation frequency is two orders of
magnitude less than at the disease site; it is somewhat higher
than expected from other estimates [10,11], but those
estimates are presumably from younger reproducing-age
individuals, whereas donor 374 is 62 y old and has had
approximately seven times more adult phase generations to
accumulate mutations. The lack of any foci with very high
mutation frequencies suggests that Luria and Delbruck [29]
jackpot formation is rare in the human testis, and that
something is fundamentally different between this CpG site
and the Apert 755 disease CpG site.
Discussion
In theory, heritable nucleotide substitutions can arise in
any germline cell during scheduled DNA replication or in
nondividing cells by means of error-prone DNA repair (see
[32]). Two observations support the importance of the cell
division–dependent mutation process. First, neutral germline
mutations seem to arise 3–6-fold more frequently in males
than females in many organisms, including humans (male-
driven evolution, see [33]). Second, a number of genetic
conditions including Apert syndrome appear to increase in
the offspring of men as they age (paternal age effect
[1,12,15,30,31]). Both male-driven evolution and the paternal
age effect can be explained by the cell division–dependent
mutation process, because cell divisions of self-renewing
spermatogonia occur throughout a man’s life, whereas the
cellular precursors of eggs (oogonia) cease replication during
the fetal life of a female [1,15].
We examined the molecular anatomy and frequency of the
Apert syndrome C755G mutation in normal human testes to
test whether the high mutation frequency was due to an
exceptionally high C-to-G transversion mutation rate per cell
division. The results show that the observed C755G mutation
frequency and distribution within the testes cannot be
explained by this hot spot model (p , 10
 6).
An alternate hypothesis to explain the high C755G
mutation frequency argues that diploid premeiotic cells
carrying the C755G mutation have a selective advantage over
wild-type cells [4,5,12,13]. In one case [5], the authors cited
the puzzling observation that the magnitude of the sex bias
for the C755G Apert syndrome is at least 99-fold greater in
the male germline than in the female germline [34,35],
whereas estimates of male bias (male-driven evolution) using
data on neutral mutations at many different sites would
indicate only an ;5-fold male preference [33,36,37]. Rare
patients with multiple mutations in the FGFR2 gene that
leads to Apert syndrome were also cited as support for a
germline selection model [13]. Finally, in another study [4],
the authors exploited a nearby single nucleotide polymor-
phism (SNP) to argue that selection acted on the C755G
mutation (however, see Text S1 and Figure S1).
In our experiments, we were not only able to clearly reject
the hot spot model, but also we could show that modifying
our model of germline development by incorporating a
simple selection scheme led to predictions on mutation
frequency and testis distribution consistent with our data.
This selection takes place on SrAp cells carrying the C755G
mutations that arise at approximately the frequency expected
from the existing data on neutral mutations [10,11]. The
selection model proposes that mutant adult SrAp occasion-
ally divide symmetrically (inferred rate 1 out of 100 divisions
on average, or approximately once every 4 y), whereas wild-
type SrAp always undergo asymmetric self-renewal divisions.
Considering all of the published work [4,5,12,13] as well as our
present results, it now seems very likely that positive selection
can be a driving force acting to increase the germline
mutation frequency in humans above the frequency at which
spontaneous nucleotide substitutions arise.
We would like to emphasize that the type of selection we
are discussing is on diploid premeiotic cells. Previous
proposals have suggested that C755G mutation bearing sperm
may have a selective advantage over wild-type sperm [3,38].
Selection taking the form of competition among sperm is well
known in plants and animals [39], and is even documented in
primates [40]. However, for this particular mutation, the
testis and epididymal sperm data we collected as well as data
on ejaculated sperm ([3,4] and unpublished data) and Apert
syndrome birth data [6,7] show similar mutation frequencies.
Therefore, while further selection on sperm is possible, we
believe that the vast majority of the increase in mutation
frequency is due to selection on the diploid premeiotic cells.
Why should a mutation that has a distinct selective
disadvantage when present in all the cells of an organism
have a selective advantage when present only in a small
fraction of the germline cells? It is worth noting here that
achondroplasia, the most common cause of dwarﬁsm, has
many similarities to that of Apert syndrome (see [5]). Virtually
all of the new achondroplasia mutations arise in the male
germline at one nucleotide site (G1138A) in the ﬁbroblast
growth factor receptor 3 (FGFR3) gene and with a mutation
frequency even higher than the C755G mutation in FGFR2.
These common characteristics suggest that the G1138A
mutation may also increase to such a high frequency by a
selective mechanism [4,5,12,13]. It is interesting to note that
both FGFR2 and FGFR3 are receptor tyrosine kinases and can
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Human Germline Mutationinﬂuence downstream members of the signal transduction
pathway (for a more detailed discussion see [41,42]).
Especially relevant may be the fact that some mutations in
FGFR2 and FGFR3 (although usually not the speciﬁc
mutations that cause Apert syndrome or achondroplasia)
have been associated with certain cancers [43,44] and cancer
susceptibility [45].
Germline selection in diploid germ cells of animals was
considered by the population geneticist Ian Hastings [46,47].
He examined how mitotic gene conversion and somatic
crossing over events in diploid germline cells of animals could
lead to loss of heterozygosity of recessive alleles and the
possibility of positive or negative selection on such alleles. He
calculated that selection against rare germline cells made
homozygous for a recessive allele can effectively lower the
transmission of the deleterious allele to offspring thereby
reducing disadvantageous alleles entering the population and
burdening it with reduced viability or fertility. Using
plausible models, this reduction in the mutational load could
be as large as 100-fold. Similarly, loss of heterozygosity could
allow recessive alleles that conferred a germline advantage to
be spread more quickly in the population. Experimental
literature on germline selection in premeiotic diploid cells in
animals is very sparse (see [48] and references therein) but in
one case, wild-type Drosophila cells were produced by a genetic
trick in the germline of females heterozygous for a
phenotypically recessive mutation and were found to have a
proliferative selective advantage compared to the back-
ground heterozygous cells.
Hastings’ analysis was primarily concerned with recessive
alleles that were already polymorphic in the population. But
gain-of-function mutations that arise sporadically in the testis
would behave in the same way, because a second event leading
to loss of heterozygosity is not required for positive and
negative selection to be effective. A new gain-of-function
mutation with a germline selective advantage will more likely
be transmitted to the next generation, because the effective
mutation frequency is elevated beyond the level that can be
achieved by the mutation process alone. A disadvantageous
gain of function mutation would be less likely to be tested in
the population if it were selected against in the germline.
Finally, Hastings realized that alleles conferring a selective
advantage in the germline may be disadvantageous in the
adult and might lead to ‘‘mitotic drive’’ systems that could
increase the mutational load of a population. Both Apert
syndrome and achondroplasia may be examples of such a
system, and additional examples of mutations of medical
interest may also exist (see [15,30,31,33]). The method we have
developed can be used to test this hypothesis at any locus in
many different species if a sufﬁciently sensitive mutation
assay can be made available.
Materials and Methods
Source of testes. Both testes from each of two donors (374, 62 y old,
and 854, 54 y old) were supplied by the National Disease Research
Interchange (NDRI) in Philadelphia, PA, United States. The testes
were frozen no longer than 10 h post mortem and stored at  80 8C.
Procurement of the testes from the NDRI was approved by the
Institutional Review Board of the University of Southern California.
Testis and epididymis processing. The epididymis was removed
from the testis. Sperm cells were collected from the tail of each
epididymis and the ﬁrst ;3 cm of the adjacent vas deferens after they
were cut into small pieces and incubated in 25 ml of 2.2% sodium
citrate with shaking for 60 min at room temperature. Sperm cells
were concentrated by centrifugation at 6000g. Sperm DNA was
isolated using a Puregene DNA puriﬁcation kit and protocol
(Gentra Systems; http://www1.qiagen.com/Products/dna.aspx) except
that 40 mM DTT was added to the lysis solution. Each testis was
ﬁxed in 70% ethanol at 4 8C for about 3 d. Three of the four testis
(374–1, 374–2 ,and 854–2) were each cut into six slices and each slice
further divided into 32 pieces. The dissection scheme and how the
position of each piece within the testis was recorded is shown in
Figure 1. Figure S2 shows the slightly different scheme that was used
only on testis 854–1. An introduction to testis anatomy can be
found at: http://training.seer.cancer.gov/ss_module11_testis/
unit02_sec01_anatomy.html. DNA was extracted using a Puregene
kit (Gentra Systems). DNA concentrations were estimated using real-
time PCR and primers for a unique sequence on Chromosome 21
(additional details are found in Text S1). The number of genomes
estimated for each testis piece is presented in Table S1.
Measurement of the FGFR2 C755G mutation frequencies in testis
and epididymal sperm DNA samples. The assay for C755G mutations
resembles an allele-speciﬁc PCR (ASPCR) that ampliﬁes mutant but not
wild-type molecules using a primer whose 39 end contains a base that is
complementary to the mutant [49–51]. The most critical difference
betweenASPCRandthemethodweused(pyrophosphorolysis-activated
PCR, or PAP [52,53]) is that both PAP primers are blocked at their 39
ends with a dideoxynucleoside monophosphate (ddNMP). The PAP
primers anneal perfectly to the mutant template but anneal to the wild-
type template with 39 terminal mismatches (Figure S3). Primer
extension by DNA polymerase, and thus PCR, is not expected to occur
in either case. However, we used a DNA polymerase (in our case
TMA31FS [54]) capable of both efﬁcient pyrophosphorolysis of ddNMP
terminated primers (thereby unblocking them) and primer extension
using dNTPs. The pyrophosphorolysis and ampliﬁcation preferentially
occurs using the mutant templates. PAP is far more selective than
conventional ASPCR for rare mutation detection. If the TMA31FS
polymerase mistakenly removes a mismatched terminal ddNMP,
insertion of the correct (templated) nucleotide simply results in the
generation of another copy of the wild-type template and not loss of
selectivity. To measure the mutation frequency of a DNA sample, 25-ll
PAP reactions were carried out in 96-well plates [Opticon 2, MJR
(BioRad; http://www.biorad.com)] or 10-ll reactions in 384-well plates
[ABI 7900HT (Applied Biosystems; http://www.appliedbiosystems.com)
or Roche LightCycler 480 (Roche Applied Science; http://www.roche.
com)]. Each reaction contained 20 mM HEPES (pH 7.5), 30 mM KCl, 50
lMN a 4PPi, 2 mM MgCl2,8 0lMo fe a c hd N T P ,8 0 – 2 0 0n Mo fe a c h
primer, 2 lM Rox, 0.2 X Syber Green I, 0.04 unit/ll TMA31FS DNA
polymerase (Roche Molecular Systems), and 25,000 copies of testis or
epididymalspermDNAmolecules.ResearchsamplesofTMA31FSDNA
polymerasemaybeobtainedfromThomasW.Myers,Director,Program
in Core Research, Roche Molecular Systems, 1145 Atlantic Avenue,
Alameda, CA 95401, USA (thomas.myers@roche.com). The sequences
(see accession numbers) of the C755G-speciﬁc PAP primers used in
these experiments are: 5’-CCCCACTCCTCCTTTCTTCCCTCTCTC
CACCAGAGCGAT(ddG) and 5’-TTTGCCGGCAGTCCGGCTTGGAG
GATGGGCCGGTGAGGC(ddC).. The 79-bp PAP product makes detec-
tion possible using quantitative PCR . The primers were synthesized by
Biosource International (http://www.biosource.com) or Biosearch Tech-
nologies (http://www.biosearchtech.com). The PAP primer ending in a
ddC was synthesized by conventional methods. The PAP primer ending
with ddG required synthesis using 5’-CE phosphoramidites. The ddNTP
at the 3’ end of each primer is complementary to nucleotide 755 but
each to different strands.
The PAP cycling conditions included an initial denaturation step
of 2 min at 948C followed by 150 cycles of 6 s at 94 8C and 40 s at 78
8C. Positive reactions could easily be distinguished from negative ones
by considering the kinetics of the increase in ﬂuorescence with cycle
number and the melting proﬁle of the ﬁnal PCR product. For sample
PAP data, see Figure S4.
Measurement of the control mutation frequencies in testis and
epididymal sperm DNA samples. For the control, we measured the
frequency of a C-to-G transversion at a CpG site on human
Chromosome 7. The C nucleotide is known to be polymorphic in
the human population (see accession numbers). Testis donor 374 was
genotyped and found to be a C/C homozygote and thus his testis and
sperm cells could be examined for the presence of C-to-G trans-
version mutations at this site. To measure the frequency of mutation,
10 ll PAP reactions were carried out in 384-well plates (ABI 7900HT,
Applied Biosystems). Each reaction contained 20 mM HEPES (pH
7.5), 30 mM KCl, 50 lMN a 4PPi, 2 mM MgCl2,8 0lM of each dNTP,
200 nM of each primer, 2 lM Rox, 0.2 X Syber Green I, 0.04 unit/ll
TMA31FS DNA polymerase (Roche Molecular Systems), and 25,000
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sequences of the C755G-speciﬁc PAP primers are: 59-TATTAATA
TAACTTAGTATCTGTCACCCCAAGGGAACCAA(ddG) and 59-TAT
TAATATAGAGTATTGACTCTTATTCTTGGGCTTCGAC(ddC). Note
that the ten 5’-most nucleotides of these primers are not comple-
mentary to the mutated target sequence. An 81-bp PAP product
results. The PAP cycling conditions included an initial denaturation
step of 1 min at 94 8C followed by 134 cycles of 6 s at 94 8C and 40 s at
70 8C.
Mutation counting strategy. A total of 40 reactions containing
25,000 genomes each (a total of 10
6 genomes) were used to estimate
the C755G mutation frequency for every piece of testes 374–1 and 2.
In those cases where fewer than 25/40 reactions were positive, we took
the number (after Poisson correction) as an estimate of the C755G
mutation frequency for that piece. If 25 or more reactions were
positive, then the experiment was repeated using 10-fold dilutions
until a dilution of the DNA from the piece was found to give fewer
than 25/40 positives.
Based on the mutation frequency results from the ﬁrst pair of
testes, a slightly different strategy was used for testes 854–2 and the
upper right and tail half (UR and TH, respectively) parts of 854–1
(Figure S2). First, ten reactions were carried out on every piece (total
of 250,000 genomes analyzed). In the case of those pieces where four
or fewer reactions were positive, we took the number (after Poisson
correction) as an estimate of the C755G mutation frequency. In those
cases where ﬁve or more of the ten reactions were positive, we carried
out additional experiments using 40 reactions (1,000,000 testis
genomes) and appropriate dilutions in the manner described for
the 374 testes. Repeated measurements from the same piece had an
average deviation of 32% from the mean value.
For all mutation counting, the estimate of the total testis mutation
frequency was the average of the frequencies of the pieces weighted
by the number of genomes in those pieces. For a positive assay
control, ten or 20 Apert C755G mutant molecules from a patient
heterozygous for the C755G mutation (kindly provided by Dr. Mimi
Jabs, Johns Hopkins Medical Institutions) were added to 500,000
human genomes and divided into 20 reactions (an average of 0.5 or 1
mutants per reaction). Negative assay controls consisted of 25,000
genomes of nongermline human blood DNA from normal individuals
(Clontech; http://www.clontech.com). Over the course of our study, we
observed an assay background in human blood DNA of between 6.63
10
 8 and 2.4310
 7, based on experiments using ;67,000,000 control
genomes. This places an upper limit on the possible mutation
frequency in human white blood cells, although it would be lower if
false positives can also result from artifacts of the assay itself.
The method for counting the Chromosome 7 control C-to-G
transversion mutations was identical to that used for testes 854–2 and
the UR and TH parts of 854–1. For a positive control, 20 mutant
genomes of blood DNA from a heterozygous (C/G) individual were
added to 500,000 human genomes from individuals homozygous for
the C allele and divided into 20 reactions (an average of one G allele-
containing genome per reaction). Negative controls consisted of 20
reactions (a total of 500,000 genomes) of blood DNA from individuals
homozygous for the C allele.
Biological basis for the model. Classical cytological approaches
provide our main source of information about human germline
development and maturation [1,15–28]. Not long after fertilization,
human primordial germ cells arise in the developing human embryo
and migrate to the embryonic sites of testis formation (genital ridges).
The germ cells become organized into seminiferous tubules,
proliferate, and differentiate into gonocytes and fetal spermatogonia.
By the beginning of puberty, the seminiferous tubules are composed
primarily of spermatogonia and supporting Sertoli cells. The
spermatogonia (including the adult SrAp) are located in their niche
at the periphery of the tubule and in intimate association with Sertoli
cells. After puberty, seminiferous tubules also contain B spermato-
gonia [17] that are derived from the asymmetric division of SrAp. B
spermatogonia are a precursor of meiotic cells. Four B spermatogo-
nia and eventually 16 sperm are thought to result from each division
of one SrAp [16,17,21,24]. In spermatogenesis, both meiotic and post-
meiotic cells gradually move from the periphery toward the lumen of
the tubule. Sperm enter the lumen of the tubule (spermiation) and
are transported to the epididymis, where they undergo further
development and are stored. Note that in a seminiferous tubule
segment, any mutant SrAp will be in close proximity to its
spermatogonial, meiotic, and post-meiotic cell descendants that will
carry the same mutation. Although SrAp divide every 16 d, it takes
much longer than 16 d for the division products of one to yield sperm
[18]. This creates overlapping ‘‘generations’’ of different germline cell
types that are found in close proximity to one another and all derived
from the same SrAp cell.
Quantitative modeling. We model the testis in two phases (Figure
3). In the ﬁrst phase between zygote formation and puberty, called the
growth phase, self-renewal cells divide symmetrically to produce two
self-renewal cells. This continues for g generations. In this phase, the
testis grows exponentially from one self-renewal cell to 2
g self-
renewal cells. The total number of divisions in the testis in this phase
is (2
g   1). This corresponds to a total of (2
gþ1   2) daughter cells
being produced, and there are this many opportunities for
replication-dependent mutations. There is a mutation rate per cell
division k at the disease site. A mutation is shared by all of a cell’s
descendants, so a mutation early in the growth phase will produce
many mutants. To be more speciﬁc, a mutation at the kth generation
will produce 2
g k mutant descendants. This concept, ﬁrst noted by
Luria and Delbruck [29] in bacteria, can lead to a ‘‘mutation jackpot.’’
Since the germ cells would be expected to stay in close proximity to
their ancestors, any such early mutations will result in regions of the
testis with high mutation frequencies. We will discuss the spatial
details in the Spatial Structure section below.
Zhengwei et al. measured on average 656,000,000 type A
spermatogonial cells per testis [23]. Using the number of genomes
per testis we have measured, the distribution of the different cell
types in Table 2 of [23] (to add sperm, see [20]), and the ploidy of
these different cell types, we infer that for donor 374, each testis has
approximately 480,000,000 type A spermatogonial cells and that for
donor 854, each testis has approximately 260,000,000 type A
spermatogonial cells. Because one-half of the type A spermatogonial
cells are SrAp [20,24,55], we estimate the number of growth phase
generations g is 27 or 28. We have also considered higher numbers
from the literature (30 [15] or 34 [19]).
In the second phase, called the adult phase, SrAp divide asym-
metrically to produce one SrAp and another cell whose descendants
will ultimately produce sperm. In this phase, the number of SrAp
remains constant. These cells divide every 16 d [18], so assuming this
phase begins at puberty (age 13), donor 374 who is age 62 has
experienced a¼1,127 adult phase generations, and donor 854 who is
age 54 has experienced a ¼ 943 adult phase generations. The total
number of divisions in the testis in this phase is equal to (a32
g). For
these donors, there are approximately 500 (’a 3 2
g/2
gþ1) more
opportunities for replication-dependent mutation in the adult phase
than in the growth phase, and because we assume identical mutation
rates per cell division in both the growth and adult phases, there will
also be, on average, this many more mutations in the adult phase.
These mutations will be randomly spread throughout the testis.
Unlike in the growth phase, mutations in the adult phase lead to only
a single mutated SrAp (and approximately 25 other mutated germ
cells [23]). If the testis mutation frequency is f, then f 4 a is an upper
bound for the mutation rate k (this inequality ignores mutations in
the growth phase).
We examine two modiﬁcations to this model. First we consider
replication-independent mutations. The number of these mutations
is proportional to time rather than the number of divisions. The
literature is not deﬁnitive [27,28], but it appears that most of the
growth phase generations occur in approximately 1 y (the 9 mo of
embryonic and fetal development plus possibly several months of
infancy). There may be several further growth phase generations in
the ;13 y before the adult phase begins; however, the number of such
generations is small enough that any mutations in these years, like in
the adult phase and unlike in the growth phase, will not produce
signiﬁcant mutation clusters (in the absence of selection). Then,
letting z be the age of the donor, the ratio of replication-independent
mutations that cannot cause signiﬁcant mutation clusters to those
mutations that will cause such clusters is (2
g 3 z)/(2
gþ1/g). For our
donors, this ratio is at least 700 to 1, even more extreme than for the
replication-dependent mutations. Consequently it would be difﬁcult
for a model incorporating replication-independent mutations to
explain our testis data.
The second modiﬁcation we consider is selection. We introduce a
new parameter into the model: at each adult phase generation, with
probability p, a mutated SrAp divides asymmetrically, and with
probability 1   p it divides symmetrically to produce two mutated
SrAp. This symmetric division is like that in the growth phase, except
that afterward, each daughter SrAp reverts to having asymmetric
divisions until the next rare symmetric division occurs; a similar
model was independently proposed in a recent publication [12]. The
occasional symmetric divisions allow mutated SrAp to grow locally in
number over time, and thereby increase the overall mutation
frequency in the testis. On average, a mutation in this phase will leave
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descendants (if a mutation occurs with x generations remaining, it
leaves on average (1 þ p)
x descendants, the time of a mutation is
uniform on [0, a]). Since the mutation probability and p are small, the
number of self-renewal cells will still stay roughly constant in the
adult phase.
Spatial structure. Above we discussed the number of mutant cells
with regard to our various models, now we will discuss their spatial
distribution. For simplicity, we have assumed that the testis is in the
shape of a rectangular box, and it is divided into a regular grid of 63
834¼192 cubic testis pieces (Figure 1). If a mutation event occurs in
the growth phase after testis formation, then there is a mutation
cluster where all of the SrAp cells in a cubic region are mutants.
Depending on the size of this cluster, it may be contained within one
of the testis pieces, intersect parts of several adjacent testis pieces, or
contain all of one or more testis pieces and intersect parts of the
surrounding testis pieces. The number of mutants in a cluster
depends on the cell generation in which the mutation event occurred
and is discussed in the previous paragraphs. The size of a cluster is
calculated assuming that it has the same density of SrAp cells as the
rest of the testis, and the total testis has 2
g SrAp cells. We set the units
so that 1 is the length of one of the 192 testis pieces. Then a mutation
at the kth generation will produce a cubic mutation cluster with
length (192 3 2
 k)
1/3. To consider some examples, a mutation at the
ﬁrst generation means half of the testis is mutated, a mutation at the
8th generation produces a cluster with 91% of the length and 75% of
the volume of one of the testis pieces, a mutation at the 21st
generation produces a cluster with 5% of the length and 0.01% of the
volume of one of the testis pieces. The location of a cluster is random
within the testis.
We assume that at the beginning of the adult phase, there is an
equal fraction of the 2
g SrAp cells (mutated or not) in each of the 192
testis pieces. During the adult phase, mutation events occur randomly
throughout the testis. If p ¼ 0, then each such mutation event
produces only one mutant SrAp cell. If p . 0, then each mutation
event produces a cluster of mutant SrAp cells. The number of
mutants in a cluster is discussed in the previous paragraphs. For
simplicity, we assume that the shape of a cluster is a cube. The size of
a cluster is calculated assuming that the cluster has the same density
of SrAp cells as the rest of the testis. Depending on the cluster’s size, it
may be contained within one testis piece or intersect several adjacent
testis pieces. Unlike the growth-phase clusters, the SrAp cells in the
selection clusters are in addition to the nonmutated SrAp cells in the
testis pieces. Due to the exponential growth of these selection
clusters, there is a relatively narrow range of realistic parameter
values for p. For example, a mutation early in the adult phase will
produce a cluster approximately 10
 5 the size of the testis if p is 0.01,
whereas this same cluster will be larger than the rest of the testis if p is
0.03 or greater. Multiple mutation clusters may intersect the same
testis piece and a given cell may only be mutated once (there are no
reverse mutations).
Testing the model. We have written a computer program
(Protocol S1 or download from http://rd.plos.org/pbio.0050224) to
simulate the model and its modiﬁcations. We ﬁx the parameters a ¼
1,127 for donor 374 and a¼943 for donor 854, and consider both the
extremes g ¼ 27 and g ¼ 34. First we consider the mutation hot spot
model (p ¼ 0). We simulated the model many times to estimate the
probability that the simulated mutation frequency is within 5% of
the observed mutation frequency as a function of the mutation
parameter k (mutation rate per cell division). The k that optimizes
this quantity is our approximate maximum likelihood estimate (this
technique is sometimes called a rejection sampler) and standard
methods can produce approximate 95% conﬁdence sets. For the
selection model (p . 0), there are two parameters to consider: p and
k. There are an inﬁnite number of pairings of these parameters’
values (a subset of parameter space) for which the model can match
the observed mutation frequency. Consequently, we searched for the
parameter values which optimized the following two-criteria
probability: (a) that the simulated mutation frequency is within
=5% of the observed frequency, and (b) that the simulated fraction
of testis’ genomes in the fewest number of testis’ pieces necessary to
contain 95% of the mutants is within =5% of this observed
quantity. Note that for the mutation hot spot model (p¼0) this two-
criteria probability is 0 for all values of k, since no single value of k
can match both criteria. In general, to estimate the empirical
likelihood, we simulated the model 1,000 times for each set of
parameter values.
To determine whether the distribution of mutations in the 192
pieces is consistent between the model and the data, we used two
hypothesis tests. First we counted the number of pieces with mutation
frequencies in each of the eight color categories in Figure 2 ([0–25/
million], etc.). For both the mutation hot spot model (p ¼ 0) and the
selection model (p . 0), we simulated the model under optimal
parameters and counted the number of pieces with frequencies in
these same categories, and then performed the chi-squared test. For
the control site, since the observed frequencies are much lower, we
considered the following four categories: [0–4 3 10
 6), [4 3 10
 6–9 3
10
 6), [9 3 10
 6–1.4 3 10
 5), [1.4 3 10
 5þ). The notation [x–y) means
frequencies f such that x   f , y.
Because a mutation cluster can overlap adjacent testis pieces, this
dependence makes the chi-squared test anticonservative. In order to
not reject the selection model (p . 0), this test is sufﬁcient; however,
in order to reject the hot spot model (p¼0), we have also performed a
goodness-of-ﬁt test. For each simulation, we computed the following
statistic: the minimum fraction of testis pieces which contain at least
95% of the total mutants. We simulated the hot spot model under the
optimal parameters and recorded this statistic for those simulations
such that the total testis mutation frequency was within 5% of the
real data. We repeated this procedure such that 1,000,000 simulations
met this criterion (under optimal parameters over 90% of simu-
lations met the criterion). The simulated statistic was never lower
than 90%, in contrast with the much lower values for the real data in
Table 1 (,6%). Therefore an empirical p-value is ,10
 6. However,
this value is just a function of our patience in running simulations; we
contend that for however many simulations are run, this statistic will
never be lower than for the data. In order to get a p-value
independent of the number of simulations, we ﬁt the distribution
of simulated statistics to a t-distribution (admittedly a poor ﬁt) and
the statistics for the real data were over 300 standard deviations away,
making the p-value less than 10
 200. The (anticonservative) chi-
squared test rejected the hot spot model with p-value less than 2 3
10
 16. Regardless of which p-value is used, there is strong support to
reject the hot spot (p ¼ 0) model.
Supporting Information
Figure S1. Simulations from Our Neutral Model
The blue lines depict the 25% and 75% quantiles of the allelic skew,
and the red line depicts the median skew, as a function of mutation
frequency.
Found at doi:10.1371/journal.pbio.0050224.sg001 (6 KB PDF).
Figure S2. Alternate Testes Dissection Strategy
Testis 854–1. The testis was divided in half as in Figure 1 and then the
head half was cut in half again parallel to the epididymal axis to
produce two pieces containing ;1/4–1/3 of the whole testis. The
portion labeled UL (i) was then divided into 192 pieces each
approximately four times smaller than was the case for testis 374.
The UR (ii) and the TH (iii) portions were dissected so that the
average piece size was approximately the same as that obtained for
testis 374.
Found at doi:10.1371/journal.pbio.0050224.sg002 (2.1 MB PDF).
Figure S3. Annealing of Mutant-Speciﬁc PAP Primers to Wild-Type
and Mutant DNA Templates
For additional information, see Methods. Only the 39 portions of the
primer sequences are shown.
Found at doi:10.1371/journal.pbio.0050224.sg003 (12 KB PDF).
Figure S4. Example of PAP Results
Ten PAP reactions were carried out on DNA from a piece of Testis
854–2.
(A) Ampliﬁcation curves (linear plot) show the increase in
ﬂuorescence as a function of cycle number. Note that the displace-
ment of the curves from one another does not signal different
starting amounts of target DNA, because on average, 90% of the
wells should have no more than one target according to the Poisson
distribution. Five of the samples gave positive curves and ﬁve were
negative.
(B) Melting proﬁles of the ten reactions shown in (A). Only the ﬁve
positive reactions gave the correct melting proﬁle for the expected
PAP product. The negative control reactions (unpublished data)
indicated no product was formed.
Found at doi:10.1371/journal.pbio.0050224.sg004 (75 KB PDF).
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Human Germline MutationProtocol S1. Computer Simulation Program
Found at doi:10.1371/journal.pbio.0050224.sd001 (55 KB DOC).
Table S1. C755G Mutation Frequency and Genome Number (Testes
374 and 854)
Found at doi:10.1371/journal.pbio.0050224.st001 (52 KB XLS).
Table S2. Control Mutation Frequency and Genome Number (Testis
374)
Found at doi:10.1371/journal.pbio.0050224.st002 (40 KB XLS).
Text S1. Supporting Information
Found at doi:10.1371/journal.pbio.0050224.sd002 (22 KB PDF).
Accession Numbers
The Online Mendelian Inheritance in Man (www.ncbi.nlm.nih.gov/
omim/) accession number for Apert syndrome is 101200. The
National Center for Biotechnology Information (NCBI; http://www.
ncbi.nlm.nih.gov/) Nucleotide accession number for the FGFR2 gene
is NM_000141. The Single Nucleotide Polymorphism database
(http://www.ncbi.nlm.nih.gov/projects/SNP/) build 127 transversion
for the C nucleotide site on human Chromosome 7 is rs3801993.
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